Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Mechanism of action of T-614 in RA examined in vitro

Feb. 15, 1999

SmithKline Beecham claims new series of inhibitors of cytokine production

Feb. 15, 1999

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

Celebrex receives approval in Mexico

Feb. 12, 1999

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

Feb. 12, 1999

Synvisc relieves pain, delays need for total knee replacement in osteoarthritis

Feb. 12, 1999

Antiinflammatory/immunosuppressant agents acting on p38 MAP kinase designed at Novartis

Feb. 11, 1999

Fenamate-derived antiinflammatory agents in development at Abbott

Feb. 10, 1999

Subgroup-selective integrin binding inhibitors patented by Celltech

Feb. 5, 1999

New Celgene compounds reduceTNF-alpha levels and NF-kB activity

Feb. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...